Cliniphar Ltd. (TYO:432A)

Market Cap	1.45B
Revenue (ttm)	3.70B +3.2%
Net Income	161.00M
EPS	161.00
Shares Out	1.00M
PE Ratio	9.01
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	1,450.00
Previous Close	1,450.00
Day's Range	1,450.00 - 1,450.00
52-Week Range	1,450.00 - 1,450.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Cliniphar

Cliniphar Ltd. operates pharmaceutical b2b e-commerce platforms in Japan and internationally. The company operates Kosei Market, a domestic pharmaceutical e-commerce platform that handles prescription pharmaceuticals and other related products used in medical industry. It also operates Synapse, a prescription pharmaceutical database that offers information in English on prescription pharmaceuticals approved in Japan, as well as supports procurement by providing quotation and ordering functions. The company was founded in 2017 and is based in Ch...

• Industry: Computer Programming, Data Processing, And Other Computer Related Services
• Founded: 2017
• Country: Japan
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 432A

Financial Performance

In fiscal year 2026, Cliniphar's revenue was 3.70 billion, an increase of 3.21% compared to the previous year's 3.59 billion. Earnings were 161.00 million, a decrease of -15.26%.